Erlotinib Terminated Phase N/A Trials for Cancer, Breast Treatment

IndicationsStatusPurposePhase
TerminatedTreatmentNot Available
clinicaltrials.gov IdentifierTitleDrugs
NCT00503841Erlotinib in Treating Women Undergoing Surgery For Stage I, Stage II, or Stage III Breast Cancer